Literature DB >> 22469524

Seizure control for patients undergoing meningioma surgery.

Kaisorn L Chaichana1, Courtney Pendleton, Hasan Zaidi, Alessandro Olivi, Jon D Weingart, Gary L Gallia, Michael Lim, Henry Brem, Alfredo Quiñones-Hinojosa.   

Abstract

OBJECTIVE: Seizures are common among patients with meningiomas and are a significant cause of morbidity and poor quality of life. The factors associated with the onset of seizures as well as factors associated with seizure control remains poorly understood.
METHODS: Adult patients who underwent primary resection of a supratentorial World Health Organization grade I meningioma at a single institution between 1996 and 2006 were retrospectively reviewed. Multivariate logistical regression analyses were used to identify associations with preoperative seizures, and multivariate proportional hazards regression analyses were used to identify associations with prolonged seizure control after surgical resection.
RESULTS: Of the 626 patients in this series, 84 (13%) presented with seizures. The factors independently associated with preoperative seizures were Karnofsky performance score ≤ 80 (P< 0.0001), absence of headaches (P = 0.0006), and vasogenic edema (P = 0.007). At 48 months postoperatively, 90% were Engel class I, 3% were class II, 0 were class III, and 7% were class IV. The factors independently associated with decreased seizure control after surgical resection were uncontrolled preoperative seizures (P = 0.04), parasagittal tumors (P = 0.03), and tumors along the sphenoid wing (P = 0.05). The association between seizure recurrence and tumor recurrence trended toward but did not achieve statistical significance (P = 0.11).
CONCLUSIONS: With the widespread availability of various neuroimaging modalities, there will be increased detection of intracranial meningiomas. The identification and consideration of factors associated with seizure onset and prolonged seizure control may help guide treatment strategies aimed at improving the quality of life for patients with meningiomas.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469524     DOI: 10.1016/j.wneu.2012.02.051

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  20 in total

1.  The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis.

Authors:  Victor M Lu; Anshit Goyal; Adrian Lee; Mark Jentoft; Alfredo Quinones-Hinojosa; Kaisorn L Chaichana
Journal:  J Neurooncol       Date:  2018-12-01       Impact factor: 4.130

2.  Meningiomas: skull base versus non-skull base.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-04-07       Impact factor: 3.042

3.  Risk of Developing Postoperative Deficits Based on Tumor Location after Surgical Resection of an Intracranial Meningioma.

Authors:  Jeff S Ehresman; Tomas Garzon-Muvdi; Davis Rogers; Michael Lim; Gary L Gallia; Jon Weingart; Henry Brem; Chetan Bettegowda; Kaisorn L Chaichana
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-17

4.  Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas.

Authors:  Xiangrong Li; Chengjun Wang; Zhiqin Lin; Meng Zhao; Xiaohui Ren; Xiaohui Zhang; Zhongli Jiang
Journal:  Neurosurg Rev       Date:  2019-02-15       Impact factor: 3.042

5.  Predicting outcome of epilepsy after meningioma resection.

Authors:  Hans-Georg Wirsching; Corinne Morel; Corinne Gmür; Marian Christoph Neidert; Christian Richard Baumann; Antonios Valavanis; Elisabeth Jane Rushing; Niklaus Krayenbühl; Michael Weller
Journal:  Neuro Oncol       Date:  2015-12-18       Impact factor: 12.300

6.  Factors Associated With Pre- and Postoperative Seizures in 1033 Patients Undergoing Supratentorial Meningioma Resection.

Authors:  William C Chen; Stephen T Magill; Dario J Englot; Joe D Baal; Sagar Wagle; Jonathan W Rick; Michael W McDermott
Journal:  Neurosurgery       Date:  2017-08-01       Impact factor: 4.654

7.  Survival and recurrence for patients undergoing surgery of skull base intracranial metastases.

Authors:  Kaisorn L Chaichana; Mariana Flores; Shami Acharya; Paul Sampognaro; Chetan Bettegowda; Daniele Rigamonti; Jon D Weingart; Alessandro Olivi; Gary L Gallia; Henry Brem; Michael Lim; Alfredo Quinones-Hinojosa
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-03

8.  Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study.

Authors:  Zhe Zheng; Peng Chen; Weiming Fu; Junming Zhu; Hong Zhang; Jian Shi; Jianmin Zhang
Journal:  J Neurooncol       Date:  2013-05-24       Impact factor: 4.130

Review 9.  Epilepsy and brain tumors.

Authors:  Dario J Englot; Edward F Chang; Charles J Vecht
Journal:  Handb Clin Neurol       Date:  2016

Review 10.  Seizures in supratentorial meningioma: a systematic review and meta-analysis.

Authors:  Dario J Englot; Stephen T Magill; Seunggu J Han; Edward F Chang; Mitchel S Berger; Michael W McDermott
Journal:  J Neurosurg       Date:  2015-12-04       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.